Suppr超能文献

相似文献

1
Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2017 Jun 15;195(12):1640-1650. doi: 10.1164/rccm.201607-1408OC.
2
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2014 Oct 15;190(8):906-13. doi: 10.1164/rccm.201403-0541OC.
3
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2019 May 1;199(9):1127-1138. doi: 10.1164/rccm.201809-1650OC.
5
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2017 Jul 15;196(2):208-219. doi: 10.1164/rccm.201607-1525OC.
6
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2021 Feb 1;203(3):339-347. doi: 10.1164/rccm.202002-0460OC.
9
Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients.
Front Cell Infect Microbiol. 2019 May 21;9:149. doi: 10.3389/fcimb.2019.00149. eCollection 2019.
10
The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis.
Am J Respir Crit Care Med. 2019 Jul 15;200(2):209-219. doi: 10.1164/rccm.201809-1775OC.

引用本文的文献

5
The value of macrolides in the adjuvant treatment of pulmonary fibrosis: maybe a panacea.
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251346108. doi: 10.1177/17534666251346108. Epub 2025 Jun 24.
6
Application value of metagenomic next-generation sequencing based on protective bronchoalveolar lavage in nonresponding pneumonia.
Microbiol Spectr. 2025 Jul;13(7):e0313824. doi: 10.1128/spectrum.03138-24. Epub 2025 May 29.
7
Residual interstitial lung abnormalities post-COVID-19 infection appear independent of lung microbiota.
ERJ Open Res. 2025 May 27;11(3). doi: 10.1183/23120541.01153-2024. eCollection 2025 May.
9
Epithelial damage and ageing: the perfect storm.
Thorax. 2025 Aug 15;80(9):668-675. doi: 10.1136/thorax-2024-222060.

本文引用的文献

2
Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
Am J Respir Cell Mol Biol. 2015 Nov;53(5):585-600. doi: 10.1165/rcmb.2015-0020TR.
3
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med. 2014 Oct 15;190(8):906-13. doi: 10.1164/rccm.201403-0541OC.
4
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.
Lancet Respir Med. 2014 Jul;2(7):548-56. doi: 10.1016/S2213-2600(14)70069-4. Epub 2014 Apr 21.
5
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Lancet Respir Med. 2013 Jun;1(4):309-317. doi: 10.1016/S2213-2600(13)70045-6. Epub 2013 Apr 17.
6
Muc5b is required for airway defence.
Nature. 2014 Jan 16;505(7483):412-6. doi: 10.1038/nature12807. Epub 2013 Dec 8.
7
Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis.
Sci Transl Med. 2013 Oct 2;5(205):205ra136. doi: 10.1126/scitranslmed.3005964.
8
The role of infection in the pathogenesis of idiopathic pulmonary fibrosis.
Eur Respir Rev. 2013 Sep 1;22(129):376-81. doi: 10.1183/09059180.00000713.
9
Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2013 Nov 15;188(10):1224-31. doi: 10.1164/rccm.201302-0341OC.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验